Placebo Group C

DRUG2 trials

Sponsors

Tasly Pharmaceuticals, Inc., Inovio Pharmaceuticals

Conditions

HealthyLassa Fever

Phase 1

Dose-Escalate Study to Investigate the Safety and Tolerability of T89 in Japanese

CompletedNCT01679028

Tasly Pharmaceuticals, Inc.Healthy

Start: 2012-08-31End: 2013-02-28Updated: 2014-11-24

Dose-ranging Study: Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers in Ghana

RecruitingPACTR201910864382850

Inovio PharmaceuticalsLassa Fever

Start: 2021-01-15Target: 220Updated: 2026-09-14